Results 51 to 60 of about 21,232 (243)

Mathematical Immunogenetics I. Mathematics as Language

open access: yes, 1983
This paper summarizes approaches to developing mathematics that can act as a language for immunogenetics. The need for this has been documented by showing inadequacies of the standard symbolism.
Markowsky, George, Wohlgemuth, Andrew
core   +1 more source

Analysis of immunogenetics interlaboratory comparisons’ success rates. External quality assurance system of the Spanish Society for Immunology GECLID-SEI

open access: yesFrontiers in Genetics
Background:For many years, transplantation outcomes were uncertain and not hopeful, until histocompatibility testing spread. Common criteria for histocompatibility assays and communications’ improvement allowed an efficient organ sharing system.
M. Carmen Martín
doaj   +1 more source

HLA-DPB1*03 as Risk Allele and HLA-DPB1*04 as Protective Allele for Both Early- and Adult-Onset Multiple Sclerosis in a Hellenic Cohort

open access: yesBrain Sciences, 2020
Background: Human Leucocyte Antigens (HLA) represent the genetic loci most strongly linked to Multiple Sclerosis (MS). Apart from HLA-DR and HLA–DQ, HLA-DP alleles have been previously studied regarding their role in MS pathogenesis, but to a much lesser
Maria Anagnostouli   +8 more
doaj   +1 more source

Immunogenetics and genomics

open access: yesThe Lancet, 2001
Immunogenetic analysis of disease susceptibility has been encouraged by the identification of strong HLA associations with several diseases of uncertain cause. Weaker HLA associations exist with a large number of infectious and non-infectious diseases and the mechanisms of these effects are beginning to be uncovered.
openaire   +2 more sources

Mathematical Immunogenetics II. Antibody Incidence Structure

open access: yes, 1983
Mathematical Immunogenetics I argued for the development of mathematics as a language for immunogenetics. A three-fold factorization of a reaction matrix was seen to be the important form of a model of a first order immunogenetic system.
Markowsky, George, Wohlgemuth, Andrew
core   +1 more source

Recent advances in the immunogenetics of idiopathic inflammatory myopathy [PDF]

open access: yes, 2011
This review summarizes the previous and current literature on the immunogenetics of idiopathic inflammatory myopathy (IIM) and updates the research progress that has been made over the past decade.
Hector Chinoy   +7 more
core   +1 more source

Utility of combined CD39/CD73/CD38 expression for the detection of malignant T cells in Sézary syndrome

open access: yesBritish Journal of Haematology, EarlyView.
Summary Sézary syndrome (SS) is an aggressive cutaneous T‐cell lymphoma, characterized by erythroderma, lymphadenopathy and circulating malignant CD4+ T cells. Despite therapeutic advances, SS remains an incurable disease. Early diagnosis is therefore essential for timely therapeutic intervention; however, reliable biomarkers to identify circulating SS
Sara Marchisio   +14 more
wiley   +1 more source

IMGT, the International ImMunoGeneTics Information System

open access: yes, 2011
INTRODUCTIONIMGT, the international ImMunoGeneTics information system (http://www.imgt.org), created in 1989 by the Laboratoire d’ImmunoGénétique Moléculaire LIGM (Université Montpellier 2 and CNRS, Montpellier, France), is the global reference in ...
Marie-Paule Lefranc, Lefranc, Mp
core   +1 more source

Immunogenetics of prostate cancer: A still unexplored field of study

open access: yes, 2018
The immune system is a double-edged sword with regard to the prostate cancer (PCa) battle. Immunogenetics, the study of the potential role of immune-related polymorphisms, is taking its first steps in the treatment of this malignancy.
Gagno, Sara   +9 more
core   +1 more source

Human leukocyte antigen allele linkage disequilibrium and haplotype structure in volunteer bone marrow donors of Paraná State

open access: yesRevista Brasileira de Hematologia e Hemoterapia
Background Bone marrow transplantation has been used in the treatment of various diseases, especially hematologic diseases. The success of this treatment, among other factors, requires human leukocyte antigens (HLA) compatibility between patient and ...
Paulo Rincoski Costantino   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy